Literature DB >> 26238448

Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin αVβ3/nuclear factor-κB/interleukin-6 axis.

Naoshi Shimojo1, Ryotaro Hashizume2, Kazuki Kanayama2, Mari Hara2, Yuka Suzuki2, Tomohiro Nishioka2, Michiaki Hiroe2, Toshimichi Yoshida2, Kyoko Imanaka-Yoshida2.   

Abstract

Tenascin-C (TN-C) is an extracellular matrix protein not detected in normal adult heart, but expressed in several heart diseases closely associated with inflammation. Accumulating data suggest that TN-C may play a significant role in progression of ventricular remodeling. In this study, we aimed to elucidate the role of TN-C in hypertensive cardiac fibrosis and underlying molecular mechanisms. Angiotensin II was administered to wild-type and TN-C knockout mice for 4 weeks. In wild-type mice, the treatment induced increase of collagen fibers and accumulation of macrophages in perivascular areas associated with deposition of TN-C and upregulated the expression levels of interleukin-6 and monocyte chemoattractant protein-1 as compared with wild-type/control mice. These changes were significantly reduced in TN-C knockout/angiotensin II mice. In vitro, TN-C accelerated macrophage migration and induced accumulation of integrin αVβ3 in focal adhesions, with phosphorylation of focal adhesion kinase (FAK) and Src. TN-C treatment also induced nuclear translocation of phospho-NF-κB and upregulated interleukin-6 expression of macrophages in an NF-κB-dependent manner; this being suppressed by inhibitors for integrin αVβ3 and Src. Furthermore, interleukin-6 upregulated expression of collagen I by cardiac fibroblasts. TN-C may enhance inflammatory responses by accelerating macrophage migration and synthesis of proinflammatory/profibrotic cytokines via integrin αVβ3/FAK-Src/NF-κB, resulting in increased fibrosis.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin II; cardiac fibrosis; hypertension; remodeling; tenascin-C

Mesh:

Substances:

Year:  2015        PMID: 26238448     DOI: 10.1161/HYPERTENSIONAHA.115.06004

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

Review 1.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  Tenascin-C protects against acute kidney injury by recruiting Wnt ligands.

Authors:  Shuangqin Chen; Haiyan Fu; Songzhao Wu; Wenjuan Zhu; Jinlin Liao; Xue Hong; Jinhua Miao; Congwei Luo; Yongping Wang; Fan Fan Hou; Lili Zhou; Youhua Liu
Journal:  Kidney Int       Date:  2018-11-06       Impact factor: 10.612

Review 3.  The extracellular matrix in myocardial injury, repair, and remodeling.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

4.  Targeting the renin-angiotensin-aldosterone system in fibrosis.

Authors:  Mohammad AlQudah; Taben M Hale; Michael P Czubryt
Journal:  Matrix Biol       Date:  2020-05-16       Impact factor: 11.583

5.  Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4.

Authors:  Azhar Maqbool; Emma J Spary; Iain W Manfield; Michaela Ruhmann; Lorena Zuliani-Alvarez; Filomena O Gamboa-Esteves; Karen E Porter; Mark J Drinkhill; Kim S Midwood; Neil A Turner
Journal:  World J Cardiol       Date:  2016-05-26

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

7.  Fibroblast-Extracellular Matrix Interactions in Tissue Fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Pathobiol Rep       Date:  2016-02-05

8.  Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation.

Authors:  Lei Song; Lai Wang; Fuqiang Li; Ada Yukht; Minghui Qin; Haley Ruther; Mingjie Yang; Aurelio Chaux; Prediman K Shah; Behrooz G Sharifi
Journal:  J Am Coll Cardiol       Date:  2017-09-26       Impact factor: 24.094

Review 9.  Extracellular matrix-mediated cellular communication in the heart.

Authors:  Iñigo Valiente-Alandi; Allison E Schafer; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2016-01-14       Impact factor: 5.000

Review 10.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.